Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hawley, Carmel M"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-15 z 15
    Tytuł:
    Dialysis modality utilization patterns and mortality in older persons initiating dialysis in Australia and New Zealand.
    Autorzy:
    Ethier I; Division of Nephrology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
    Campbell SB; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
    Cho Y; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.; Australasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia.
    Hawley CM; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.; Australasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia.; Translational Research Institute, Brisbane, Queensland, Australia.
    Isbel NM; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Australasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia.
    Krishnasamy R; Australasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia.; Department of Nephrology, Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia.
    Roberts MA; Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
    Semple D; Department of Renal Medicine, Auckland District Health Board, Auckland, New Zealand.; School of Medicine, University of Auckland, Auckland, New Zealand.
    Sypek M; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.
    Viecelli AK; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Australasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia.
    Johnson DW; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.; Australasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia.; Translational Research Institute, Brisbane, Queensland, Australia.
    Pokaż więcej
    Źródło:
    Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2022 Aug; Vol. 27 (8), pp. 663-672. Date of Electronic Publication: 2022 Jun 22.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Kidney Failure, Chronic*/diagnosis
    Kidney Failure, Chronic*/epidemiology
    Kidney Failure, Chronic*/therapy
    Peritoneal Dialysis*/adverse effects
    Aged ; Aged, 80 and over ; Hemodialysis, Home/adverse effects ; Humans ; New Zealand/epidemiology ; Registries ; Renal Dialysis/adverse effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Dialysis initiation in older persons across centres and over time in Australia and New Zealand.
    Autorzy:
    Ethier I; Division of Nephrology, Centre Hospitalier de l'Université de Montréal, Montréal, Canada.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
    Campbell SB; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
    Cho Y; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia.; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
    Hawley CM; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia.; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.; Centre for Kidney Disease Research, Translational Research Institute, Brisbane, Australia.
    Isbel NM; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
    Krishnasamy R; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.; Department of Nephrology, Sunshine Coast University Hospital, Sunshine Coast, Australia.
    Roberts MA; Eastern Health Clinical School, Monash University, Melbourne, Australia.
    Semple D; Department of Renal Medicine, Auckland District Health Board, Auckland, New Zealand.; School of Medicine, University of Auckland, Auckland, New Zealand.
    Sypek M; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia.
    Viecelli AK; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
    Johnson DW; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia.; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.; Centre for Kidney Disease Research, Translational Research Institute, Brisbane, Australia.
    Pokaż więcej
    Źródło:
    Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2021 Jul; Vol. 26 (7), pp. 613-622. Date of Electronic Publication: 2021 Mar 18.
    Typ publikacji:
    Journal Article; Multicenter Study
    MeSH Terms:
    Kidney Failure, Chronic/*therapy
    Renal Dialysis/*statistics & numerical data
    Age Distribution ; Aged ; Aged, 80 and over ; Australia ; Female ; Humans ; Male ; Middle Aged ; New Zealand ; Time Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Allograft failure in kidney transplant recipients who developed kidney failure secondary to ANCA-associated vasculitis.
    Autorzy:
    Kuhnel L; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
    Hawley CM; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.; Translational Research Institute, Brisbane, QLD, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
    Johnson DW; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.; Translational Research Institute, Brisbane, QLD, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
    Gobe GC; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.; Translational Research Institute, Brisbane, QLD, Australia.
    Ellis RJ; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.; Translational Research Institute, Brisbane, QLD, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
    Francis RS; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.; Translational Research Institute, Brisbane, QLD, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
    Pokaż więcej
    Źródło:
    Clinical transplantation [Clin Transplant] 2021 Apr; Vol. 35 (4), pp. e14235. Date of Electronic Publication: 2021 Feb 06.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/complications
    Kidney Failure, Chronic*/etiology
    Kidney Failure, Chronic*/surgery
    Kidney Transplantation*/adverse effects
    Renal Insufficiency*/etiology
    Adult ; Allografts ; Humans ; Kidney ; Proportional Hazards Models
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Postoperative mortality in patients on chronic dialysis following elective surgery: A systematic review and meta-analysis.
    Autorzy:
    Palamuthusingam D; Metro South and Integrated Nephrology and Transplant Services, Logan Hospital, Meadowbrook, Queensland, Australia.; Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia.; School of Medicine, Griffith University, Mount Gravatt, Queensland, Australia.
    Nadarajah A; Department of Surgery, Sunshine Coast University Hospital, Birtinya, Queensland, Australia.
    Pascoe EM; Centre for Health Services Research, University of Queensland, St Lucia, Queensland, Australia.
    Craig J; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
    Johnson DW; Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia.; Metro South and Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
    Hawley CM; Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia.; Metro South and Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
    Fahim M; Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia.; Metro South and Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.; Metro North Hospital and Health Service, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2020 Jun 26; Vol. 15 (6), pp. e0234402. Date of Electronic Publication: 2020 Jun 26 (Print Publication: 2020).
    Typ publikacji:
    Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
    MeSH Terms:
    Elective Surgical Procedures/*mortality
    Kidney Failure, Chronic/*mortality
    Kidney Failure, Chronic/*therapy
    Postoperative Complications/*mortality
    Renal Dialysis/*adverse effects
    Adult ; Aged ; Comorbidity ; Female ; Hospital Mortality ; Humans ; Kidney Failure, Chronic/epidemiology ; Male ; Middle Aged ; Prognosis ; Risk
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Effect of centre- and patient-related factors on uptake of haemodiafiltration in Australia and New Zealand: A cohort study using ANZDATA.
    Autorzy:
    Mac K; Centre for Transplant and Renal Research, Westmead Hospital, Sydney, New South Wales, Australia.
    Hedley J; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
    Kelly PJ; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
    Lee VW; Centre for Transplant and Renal Research, Westmead Hospital, Sydney, New South Wales, Australia.; Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
    Agar JWM; Department of Nephrology, University Hospital Geelong, Geelong, Victoria, Australia.
    Hawley CM; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Australasian Kidney Trials Network, Brisbane, Queensland, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
    Johnson DW; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Australasian Kidney Trials Network, Brisbane, Queensland, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
    See EJ; Department of Nephrology, Monash Health, Melbourne, Victoria, Australia.
    Polkinghorne KR; Department of Nephrology, Monash Health, Melbourne, Victoria, Australia.
    Rabindranath KS; Department of Nephrology, Waikato District Hospital, Hamilton, New Zealand.
    Sud K; Centre for Transplant and Renal Research, Westmead Hospital, Sydney, New South Wales, Australia.; Department of Renal Medicine, Nepean Hospital, Sydney, New South Wales, Australia.; Nepean Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
    Webster AC; Centre for Transplant and Renal Research, Westmead Hospital, Sydney, New South Wales, Australia.; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
    Pokaż więcej
    Źródło:
    Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2020 Jan; Vol. 25 (1), pp. 63-72. Date of Electronic Publication: 2019 May 02.
    Typ publikacji:
    Comparative Study; Journal Article
    MeSH Terms:
    Health Knowledge, Attitudes, Practice*/ethnology
    Healthcare Disparities/*trends
    Hemodiafiltration/*trends
    Kidney Failure, Chronic/*therapy
    Practice Patterns, Physicians'/*trends
    Adolescent ; Adult ; Age Factors ; Aged ; Australia/epidemiology ; Comorbidity ; Female ; Health Status ; Healthcare Disparities/ethnology ; Humans ; Kidney Failure, Chronic/diagnosis ; Kidney Failure, Chronic/ethnology ; Male ; Middle Aged ; New Zealand/epidemiology ; Registries ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Sex Factors ; Time Factors ; Treatment Outcome ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
    Autorzy:
    Yang WL; Department of Nephrology, Peking University Third Hospital, Beijing, China.; Division of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.; Australasian Kidney Trials Network, The University of Queensland, Queensland, Australia.
    Bose B; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.; Australasian Kidney Trials Network, The University of Queensland, Queensland, Australia.; Department of Nephrology, Nepean Hospital, Kingswood, Australia.
    Zhang L; Division of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.; Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
    Mcstea M; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.; Australasian Kidney Trials Network, The University of Queensland, Queensland, Australia.
    Cho Y; Division of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.; Australasian Kidney Trials Network, The University of Queensland, Queensland, Australia.
    Fahim M; Division of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.; Australasian Kidney Trials Network, The University of Queensland, Queensland, Australia.
    Hawley CM; Division of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.; Australasian Kidney Trials Network, The University of Queensland, Queensland, Australia.; Translational Research Institute, Brisbane, Australia.
    Pascoe EM; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.; Australasian Kidney Trials Network, The University of Queensland, Queensland, Australia.
    Johnson DW; Division of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.; Australasian Kidney Trials Network, The University of Queensland, Queensland, Australia.; Translational Research Institute, Brisbane, Australia.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2019 Aug 23; Vol. 14 (8), pp. e0221531. Date of Electronic Publication: 2019 Aug 23 (Print Publication: 2019).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Kidney Transplantation*
    Registries*
    Renal Dialysis*
    Glomerulonephritis, Membranous/*complications
    Kidney Failure, Chronic/*etiology
    Adolescent ; Adult ; Aged ; Allografts ; Australia ; Cohort Studies ; Female ; Glomerulonephritis, Membranous/physiopathology ; Graft Survival ; Humans ; Kidney/physiopathology ; Kidney Failure, Chronic/physiopathology ; Male ; Middle Aged ; New Zealand ; Recurrence ; Survival Analysis ; Time Factors ; Treatment Outcome ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
    Autorzy:
    Viecelli AK; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australasian Kidney Trials Network, Faculty of Medicine, University of Queensland, Brisbane, Australia.
    Polkinghorne KR; Department of Nephrology, Monash Medical Centre, Melbourne, Australia.; Department of Medicine, Monash University, Melbourne, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
    Pascoe EM; Australasian Kidney Trials Network, Faculty of Medicine, University of Queensland, Brisbane, Australia.
    Paul-Brent PA; Australasian Kidney Trials Network, Faculty of Medicine, University of Queensland, Brisbane, Australia.
    Hawley CM; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australasian Kidney Trials Network, Faculty of Medicine, University of Queensland, Brisbane, Australia.; Translational Research Institute, Brisbane, Australia.
    Badve SV; Australasian Kidney Trials Network, Faculty of Medicine, University of Queensland, Brisbane, Australia.; Department of Nephrology, St George Hospital, Sydney, Australia.; The George Institute for Global Health, Sydney, Australia.
    Cass A; Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
    Hooi LS; Department of Medicine and Hemodialysis Unit, Hospital Sultanah Aminah, Johor Bahru, Malaysia.
    Kerr PG; Department of Nephrology, Monash Medical Centre, Melbourne, Australia.; Department of Medicine, Monash University, Melbourne, Australia.
    Mori TA; Medical School, University of Western Australia, Perth, Australia.
    Ong LM; Department of Nephrology, Penang Hospital, Georgetown, Malaysia.
    Voss D; Middlemore Renal Services, Middlemore Hospital, Auckland, New Zealand.
    Johnson DW; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australasian Kidney Trials Network, Faculty of Medicine, University of Queensland, Brisbane, Australia.; Translational Research Institute, Brisbane, Australia.
    Irish AB; The George Institute for Global Health, Sydney, Australia.; Department of Nephrology, Fiona Stanley Hospital, Perth, Australia.
    Pokaż więcej
    Corporate Authors:
    Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group
    Źródło:
    PloS one [PLoS One] 2019 Mar 26; Vol. 14 (3), pp. e0213274. Date of Electronic Publication: 2019 Mar 26 (Print Publication: 2019).
    Typ publikacji:
    Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
    Arteriovenous Fistula/*drug therapy
    Aspirin/*therapeutic use
    Fish Oils/*administration & dosage
    Kidney Failure, Chronic/*prevention & control
    Vascular Patency/*drug effects
    Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients.
    Autorzy:
    See EJ; Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
    Hawley CM; Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; School of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Translational Research Institute, Brisbane, Queensland, Australia.; Australasian Kidney Trials Network, Brisbane, Queensland, Australia.
    Cho Y; Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; School of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Australasian Kidney Trials Network, Brisbane, Queensland, Australia.
    Toussaint ND; Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia.; Department of Nephrology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
    Agar JW; Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia.; Department of Nephrology, University Hospital Geelong, Geelong, Victoria, Australia.
    Pascoe EM; Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia.; School of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Australasian Kidney Trials Network, Brisbane, Queensland, Australia.
    Lim WH; Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia.; Department of Renal Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
    Francis RS; Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
    Collins MG; Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia.; Department of Nephrology, Auckland City Hospital, Auckland, New Zealand.
    Johnson DW; Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Translational Research Institute, Brisbane, Queensland, Australia.; Australasian Kidney Trials Network, Brisbane, Queensland, Australia.
    Pokaż więcej
    Źródło:
    Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2019 Jan; Vol. 24 (1), pp. 111-120.
    Typ publikacji:
    Comparative Study; Journal Article; Multicenter Study; Observational Study
    MeSH Terms:
    Delayed Graft Function/*etiology
    Kidney Failure, Chronic/*therapy
    Kidney Transplantation/*adverse effects
    Renal Dialysis/*adverse effects
    Adult ; Australia ; Biomarkers/blood ; Cardiovascular Diseases/etiology ; Cause of Death ; Creatinine/blood ; Delayed Graft Function/mortality ; Delayed Graft Function/physiopathology ; Delayed Graft Function/therapy ; Female ; Glomerular Filtration Rate ; Graft Rejection/etiology ; Graft Survival ; Humans ; Kidney Failure, Chronic/diagnosis ; Kidney Failure, Chronic/mortality ; Kidney Failure, Chronic/physiopathology ; Kidney Transplantation/mortality ; Male ; Middle Aged ; New Zealand ; Registries ; Renal Dialysis/methods ; Renal Dialysis/mortality ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Autorzy:
    Zhang L; ANZDATA Registry, Adelaide, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
    Liu X; Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
    Pascoe EM; ANZDATA Registry, Adelaide, Australia.; Australasian Kidney Trials Network, The University of Queensland, Brisbane, Australia.
    Badve SV; ANZDATA Registry, Adelaide, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australasian Kidney Trials Network, The University of Queensland, Brisbane, Australia.
    Boudville NC; ANZDATA Registry, Adelaide, Australia.; School of Medicine and Pharmacology, Sir Charles Gairdner Hospital Unit, The University of Western Australia, Perth, Australia.
    Clayton PA; ANZDATA Registry, Adelaide, Australia.; Department of Nephrology, Prince of Wales Hospital, Sydney, Australia.; School of Public Health, University of Sydney, Sydney, Australia.
    De Zoysa J; Department of Renal Medicine, North Shore Hospital, Auckland, New Zealand.; The University of Auckland, Auckland, New Zealand.
    Hawley CM; ANZDATA Registry, Adelaide, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australasian Kidney Trials Network, The University of Queensland, Brisbane, Australia.
    Kanellis J; ANZDATA Registry, Adelaide, Australia.; Department of Nephrology, Monash Health and Department of Medicine, Melbourne, Australia.
    McDonald SP; ANZDATA Registry, Adelaide, Australia.; School of Medicine, University of Adelaide, Adelaide, Australia.
    Peh CA; School of Medicine, University of Adelaide, Adelaide, Australia.
    Polkinghorne KR; ANZDATA Registry, Adelaide, Australia.; Department of Nephrology, Monash Health and Department of Medicine, Melbourne, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
    Johnson DW; ANZDATA Registry, Adelaide, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.; Australasian Kidney Trials Network, The University of Queensland, Brisbane, Australia.
    Pokaż więcej
    Źródło:
    Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2016 May; Vol. 21 (5), pp. 387-96.
    Typ publikacji:
    Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Kidney Transplantation*/adverse effects
    Kidney Transplantation*/mortality
    Renal Dialysis*/adverse effects
    Renal Dialysis*/mortality
    Glomerulonephritis, IGA/*therapy
    Kidney Failure, Chronic/*therapy
    Australia/epidemiology ; Chi-Square Distribution ; Disease Progression ; Glomerulonephritis, IGA/diagnosis ; Glomerulonephritis, IGA/mortality ; Graft Survival ; Humans ; IgA Vasculitis/diagnosis ; IgA Vasculitis/mortality ; Incidence ; Kaplan-Meier Estimate ; Kidney Failure, Chronic/diagnosis ; Kidney Failure, Chronic/mortality ; Multivariate Analysis ; New Zealand/epidemiology ; Proportional Hazards Models ; Registries ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study.
    Autorzy:
    Roberts MA; Department of Renal Medicine, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
    Pilmore HL
    Ierino FL
    Badve SV
    Cass A
    Garg AX
    Hawley CM
    Isbel NM
    Krum H
    Pascoe EM
    Tonkin AM
    Vergara LA
    Perkovic V
    Pokaż więcej
    Corporate Authors:
    BLOCADE Study Collaborative Group
    Źródło:
    Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2015 Mar; Vol. 20 (3), pp. 140-7.
    Typ publikacji:
    Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Peritoneal Dialysis*/adverse effects
    Renal Dialysis*/adverse effects
    Research Design*
    Adrenergic beta-Antagonists/*therapeutic use
    Carbazoles/*therapeutic use
    Cardiovascular Diseases/*prevention & control
    Kidney Failure, Chronic/*therapy
    Propanolamines/*therapeutic use
    Adrenergic beta-Antagonists/adverse effects ; Australia ; Carbazoles/adverse effects ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/etiology ; Carvedilol ; Clinical Protocols ; Double-Blind Method ; Feasibility Studies ; Female ; Humans ; Kidney Failure, Chronic/complications ; Kidney Failure, Chronic/diagnosis ; Male ; Medication Adherence ; Middle Aged ; New Zealand ; Patient Selection ; Propanolamines/adverse effects ; Sample Size ; Time Factors ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The association between body mass index and mortality in incident dialysis patients.
    Autorzy:
    Badve SV; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
    Paul SK; Clinical Trials & Biostatistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
    Klein K; Clinical Trials & Biostatistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
    Clayton PA; Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
    Hawley CM; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
    Brown FG; Department of Nephrology & Medicine, Monash Medical Centre and Monash University, Melbourne, Victoria, Australia.
    Boudville N; School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.
    Polkinghorne KR; Department of Nephrology & Medicine, Monash Medical Centre and Monash University, Melbourne, Victoria, Australia.
    McDonald SP; Australia and New Zealand Dialysis and Transplant Registry, University of Adelaide at Central Northern Adelaide Renal & Transplant Services, Adelaide, South Australia, Australia.
    Johnson DW; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2014 Dec 16; Vol. 9 (12), pp. e114897. Date of Electronic Publication: 2014 Dec 16 (Print Publication: 2014).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Body Mass Index*
    Kidney Failure, Chronic/*mortality
    Renal Dialysis/*statistics & numerical data
    Adult ; Aged ; Australia ; Cohort Studies ; Female ; Humans ; Kidney Failure, Chronic/pathology ; Kidney Failure, Chronic/therapy ; Longitudinal Studies ; Male ; Middle Aged ; New Zealand ; Obesity/pathology ; Registries ; Risk ; Risk Factors ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Complications of home hemodialysis.
    Autorzy:
    Hawley CM; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia. carmel_hawley@health.qld.gov.au
    Jeffries J
    Nearhos J
    Van Eps C
    Pokaż więcej
    Źródło:
    Hemodialysis international. International Symposium on Home Hemodialysis [Hemodial Int] 2008 Jul; Vol. 12 Suppl 1, pp. S21-5.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Chronic Kidney Disease-Mineral and Bone Disorder/*etiology
    Hemodialysis, Home/*adverse effects
    Hemorrhage/*etiology
    Hypotension/*etiology
    Kidney Failure, Chronic/*therapy
    Chronic Kidney Disease-Mineral and Bone Disorder/epidemiology ; Hemodialysis, Home/statistics & numerical data ; Hemorrhage/epidemiology ; Humans ; Hypotension/epidemiology ; Kidney Failure, Chronic/epidemiology ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion.
    Autorzy:
    Wiggins KJ; Department of Renal Medicine, The University of Queensland at the Princess Alexandra Hospital, Woolloongabba, Queensland, Australia. />Rumpsfeld M
    Hawley CM
    O'Shea A
    Isbel NM
    Campbell SB
    Johnson DW
    Pokaż więcej
    Źródło:
    Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2007 Jun; Vol. 12 (3), pp. 218-23.
    Typ publikacji:
    Comparative Study; Journal Article
    MeSH Terms:
    Glomerular Filtration Rate/*physiology
    Kidney Failure, Chronic/*therapy
    Peritoneal Dialysis/*methods
    Adult ; Aged ; Body Mass Index ; Creatine/blood ; Dialysis Solutions/analysis ; Female ; Humans ; Kidney Failure, Chronic/mortality ; Male ; Middle Aged ; Prospective Studies ; Regression Analysis ; Survival Analysis ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Is it time to revisit residual renal function in haemodialysis?
    Autorzy:
    Ng TG; Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
    Johnson DW
    Hawley CM
    Pokaż więcej
    Źródło:
    Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2007 Jun; Vol. 12 (3), pp. 209-17.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Kidney/*physiopathology
    Kidney Failure, Chronic/*therapy
    Renal Dialysis/*methods
    Humans ; Kidney Failure, Chronic/prevention & control ; Membranes, Artificial ; Peritoneal Dialysis/methods ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-15 z 15

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies